Nine TFs (ETS1, SP1, GABPA, NFY, ELF1, ELK4, ELK5, Fil1 and PU.1) were predicted to be key factors in the process of BMP9 alleviating NAFLD. This evidence concerns the gene SPI1 and metabolic dysfunction-associated steatotic liver disease.